Skip to main content
Log in

Reproductive fitness in maternal homocystinuria due to cystathionine β-synthase deficiency

  • Published:
Journal of Inherited Metabolic Disease

Abstract

Early diagnosis and improved treatment are leading to the potential for increased reproductive capability in homocystinuria due to cystathionine β-synthase (CβS) deficiency, but information about reproductive outcome and risk of thromboembolism in pregnancy is limited. To provide further information, clinical and biochemical information was obtained on women with maternal homocystinuria, on their pregnancies and on the offspring. This information included blood sulphur amino acids and total homocysteine, CβS gene mutations and developmental and cognitive scores in the offspring. The study involved 15 pregnancies in 11 women, of whom 5 were pyridoxine-nonresponsive and 6 were pyridoxine-responsive. Complications of pregnancy included pre-eclampsia at term in two pregnancies and superficial venous thrombosis of the leg in a third pregnancy. One pregnancy was terminated and two pregnancies resulted in first-trimester spontaneous abortions. The remaining 12 pregnancies produced live-born infants with normal or above-normal birth measurements. One offspring has multiple congenital anomalies that include colobomas of the iris and choroid, neural tube defect and undescended testes. He is also mentally retarded and autistic. A second offspring has Beckwith–Wiedemann syndrome. The remaining 10 offspring were normal at birth and have remained normal. There was no relationship between the severity of the biochemical abnormalities or the therapies during pregnancy to either the pregnancy complications or the offspring outcomes. The infrequent occurrences of pregnancy complications, offspring abnormalities and maternal thromboembolic events in this series suggest that pregnancy and outcome in maternal homocystinuria are usually normal. Nevertheless, a cautious approach would include careful monitoring of these pregnancies with attention to metabolic therapy and possibly anticoagulation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  • Andersson A, Brattstrom L, Isaksson A, Israelsson B, Hultberg B (1989) Determination of homocysteine in plasma by ion-exchange chromatography. Scand J Clin Lab Invest 49: 445-449.

    Google Scholar 

  • Bao L, Goodman SI, Spector EB (1998) Detection of glutaryl coenzyme A dehydrogenase mutations by allele-specific oligonucleotide hybridization. Am J Hum Genet 63: A262.

    Google Scholar 

  • Calvert SM, Rand RJ (1995) A successful pregnancy in a patient with homocystinuria and a previous near-fatal postpartum cavernous sinus thrombosis. Br J Obstet Gynaecol 102: 751-752.

    Google Scholar 

  • Constantine G, Green A (1987) Untreated homocystinuria: a maternal death in a woman with four pregnancies. Case report. Br J Obstet Gynaecol 94: 803-806.

    Google Scholar 

  • Gallagher PM, Ward P, Tan S, et al (1995) High frequency (71%) of cystathionine beta-synthase mutation G307S in Irish homocystinuria patients. Hum Mutat 6: 177-180.

    Google Scholar 

  • Ghaziuddin M, Tsai LY, Ghaziuddin N (1992) Brief report: a comparison of the diagnostic criteria for Asperger syndrome. JAutism Dev Disord 22: 643-649.

    Google Scholar 

  • Gilfix BM, Blank DW, Rosenblatt DS (1997) Novel reductant for determination of total plasma homocysteine. Clin Chem 43: 687-688.

    Google Scholar 

  • Handelin B, Shuber AP (1985) Simultaneous detection of multiple point mutations using allele-specific oligonucleotides. Curr Protocol Hum Genet 6, (supplement): 9.4.1-9.4.8.

    Google Scholar 

  • Hathaway WE, Bonnan J (1987) Thrombotic disorders in pregnancy and the newborn. In Hemostatic Disorders of the Pregnant Woman and the Newborn Infant. New York: Elsevier Scientific.

    Google Scholar 

  • Kapusta L, Haagmans ML, Steegers EA, Cuypers MH, Blom HJ, Eskes TK(1999) Congenital heart defects and maternal derangement of homocysteine metabolism. J Pediatr 135: 773-774.

    Google Scholar 

  • Kluijtmans LA, Boers GH, Kraus JP, et al (1999) The molecular basis of cystathionine beta-synthase deficiency in Dutch patients with homocystinuria: effect of CBS genotype on biochemical and clinical phenotype and on response to treatment. Am J Hum Genet 65: 59-67.

    Google Scholar 

  • Kraus JP, Janosik M, Kozich V, et al (1999) Cystathionine beta-synthase mutations in homocystinuria. Hum Mutat 13: 362-375.

    Google Scholar 

  • Leeda M, Riyazi N, de Vries JI, Jakobs C, van Geijn HP, Dekker GA (1998) Effects of folic acid and vitamin B6 supplementation on women with hyperhomocysteinemia and a history of preeclampsia or fetal growth restriction. Am J Obstet Gynecol 179: 135-139.

    Google Scholar 

  • Lenke RR, Levy HL (1980) Maternal phenylketonuria and hyperphenylalaninemia. An international survey of the outcome of untreated and treated pregnancies. N Engl J Med 303: 1202-1208.

    Google Scholar 

  • Malinow MR, Rajkovic A, Duell PB, Hess DL, Upson BM (1998) The relationship between maternal and neonatal umbilical cord plasma homocyst(e)ine suggests a potential role for maternal homocyst(e)ine in fetal metabolism. Am J Obstet Gynecol 178: 228-233.

    Google Scholar 

  • McKusick VA, Hall JG, Char F (1979) The clinical and genetic characteristics of homocystinuria. In: Carson NAJ, Raiden DN (eds) Inherited Disorders of Sulphur Metabolism. Edinburgh: Churchill Livingstone, 179-204.

    Google Scholar 

  • Miller JF, Williamson E, Glue J, Gordon YB, Grudzinskas JG, Sykes A (1980) Fetal loss after implantation. A prospective study. Lancet 2: 554-556.

    Google Scholar 

  • Mills JL, McPartlin JM, Kirke PN, et al (1995) Homocysteine metabolism in pregnancies complicated by neural-tube defects. Lancet: 345: 149-151.

    Google Scholar 

  • Mudd SH, Levy HL, Kraus JD (2001) Disorders of transsulfuration. In: Scriver CR Beaudet AL, Sly WS, Valle D (eds); Childs B, Kinzler KW, Vogelstein B (assoc. eds) TheMetabolic and Molecular Bases of Inherited Disease, 8th edn. New York: McGraw-Hill, 2007-2056.

    Google Scholar 

  • Myatt L, Miodovnik M (1999) Prediction of preeclampsia. Semin Perinatol 23: 45-57.

    Google Scholar 

  • Newman G, Mitchell RJ (1984) Homocystinuria presenting as multiple arterial occlusions. Q J Med 210: 251-258.

    Google Scholar 

  • Rassin DK, Fleisher LD, Muir A, Desnick RJ, Gaull GE (1979) Fetal tissue amino acid concentrations in argininosuccinic aciduria and in ''maternal homocystinuria''. Clin Chim Acta 94: 101-108.

    Google Scholar 

  • Rosenquist TH, Ratashak SA, Selhub J (1996) Homocysteine induces congenital defects of the heart and neural tube: effect of folic acid. Proc Natl Acad Sci USA 93: 15227-15232.

    Google Scholar 

  • Schoengold DM, de Fiore RH, Parlett RC (1978) Free amino acids in plasma throughout pregnancy. Am J Obstet Gynecol 131: 490-499.

    Google Scholar 

  • Schulman JD, Mudd SH, Shulman NR, Landvater L (1980) Pregnancy and thrombophlebitis in homocystinuria. Blood 56: 326.

    Google Scholar 

  • Shih VE, Fringer JM, Mandell R, et al (1995) A missense mutation (I278T) in the cystathionine beta-synthase gene prevalent in pyridoxine-responsive homocystinuria and associated with mild clinical phenotype. Am J Hum Genet 57: 34-39.

    Google Scholar 

  • Steegers-Theunissen RP, Boers GH, Trijbels FJ, et al (1994) Maternal hyperhomocysteinemia: a risk factor for neural-tube defects? Metabolism 43: 1475-1480.

    Google Scholar 

  • Vargas JE, Levy HL (1998) Maternal and fetal considerations in metabolic disorders. J Jpn Soc Mass-Screening 8 (suppl 1): 29-45.

    Google Scholar 

  • Walker MC, Smith GN, Perkins SL, Keely EJ, Gamer PR (1999) Changes in homocysteine levels during normal pregnancy. Am J Obstet Gynecol 180: 660-664.

    Google Scholar 

  • Walter JH, Wraith JE, White FJ, Bridge C, Till J (1998) Strategies for the treatment of cystathionine beta-synthase deficiency: the experience of the Willink Biochemical Genetics Unit over the past 30 years. Eur J Pediatr 157 (supplement 2): S71-S76.

    Google Scholar 

  • Weng EY, Moeschler JB, Graham JM Jr (1995) Longitudinal observations on 15 children with Wiedemann-Beckwith syndrome. Am J Med Genet 56: 366-373.

    Google Scholar 

  • Whittaker PG, Taylor A, Lind T (1983) Unsuspected pregnancy loss in healthy women. Lancet 1: 1126-1127.

    Google Scholar 

  • Wilcken DE, Wilcken B (1997) The natural history of vascular disease in homocystinuria and the effects of treatment. J Inherit Metab Dis 20: 295-300.

    Google Scholar 

  • Yap S, Naughten E (1998) Homocystinuria due to cystathionine beta-synthase deficiency in Ireland: 25 years' experience of a newborn screened and treated population with reference to clinical outcome and biochemical control. J Inherit Metab Dis 21: 738-747.

    Google Scholar 

  • Yap S, Barry-Kinsella C, Naughten ER (2001) Maternal pyridoxine non-responsive homocystinuria: the role of dietary treatment and anticoagulation. Br J Obstet Gynaecol 108: 425-428.

    Google Scholar 

  • Young M, Prenton MA (1969) Maternal and fetal plasma amino acid concentrations during gestation and in retarded fetal growth. Obstet Gynaecol Br Commonw 76: 333-334.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to H. L. Levy.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Levy, H.L., Vargas, J.E., Waisbren, S.E. et al. Reproductive fitness in maternal homocystinuria due to cystathionine β-synthase deficiency. J Inherit Metab Dis 25, 299–314 (2002). https://doi.org/10.1023/A:1016502408305

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1016502408305

Keywords

Navigation